ExpressLane (06-15-2021)
what?
https://www.reuters.com/article/us-u...-idUSKBN23M2UO
President Donald Trump said on Monday other countries had provided great reports on the effectiveness of malaria drug hydroxychloroquine for treatment of the deadly coronavirus,
ExpressLane (06-15-2021)
Another ignorant cunt!
https://www.politifact.com/factcheck...d-coronavirus/On COVID-19, Donald Trump said that “maybe if you drank bleach you may be okay.”
Joe Biden said President Donald Trump told Americans that drinking bleach could help combat the coronavirus, but that’s not correct.
Trump did not explicitly recommend ingesting a disinfectant like bleach. But he did express interest in exploring whether disinfectants could be applied to the site of a coronavirus infection inside the body, such as the lungs.
Responding to confusion over Trump’s comments, the maker of Lysol said in a statement that "under no circumstance" should its products be used in the human body.
Last edited by cancel2 2022; 06-15-2021 at 09:26 AM.
ExpressLane (06-15-2021)
almost all the studies were HCQ by itself and the dosages varied and the time frame was too late for hospitalization.
it has to be given early, and it's best with D3/Zpak
Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
https://www.sciencedirect.com/scienc...01971220321755
cancel2 2022 (06-15-2021), ExpressLane (06-15-2021)
Rights are arguing hydroxy due to tribalism. They never want to admit what a joke Trump was. To accept the science shows Trump was wasting time and money. https://medcitynews.com/2020/08/why-...-for-covid-19/ That is the fact rightys refuse to face.
doesnt matter.
there are too many studies where the early use combined with other cohorts shows relief from cytokine storm
It's almost like they sabotaged the use by poor clinical application
it helps prevent early viral replication. and it needs support from zinc, D3 etc
ExpressLane (06-15-2021)
When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.
On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, "Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis." That article, published in the world's leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety.
Physicians who have been using these medications in the face of widespread skepticism have been truly heroic. They have done what the science shows is best for their patients, often at great personal risk. I myself know of two doctors who have saved the lives of hundreds of patients with these medications, but are now fighting state medical boards to save their licenses and reputations. The cases against them are completely without scientific merit.
Newsweek Newsletter sign-up >
Since publication of my May 27 article, seven more studies have demonstrated similar benefit. In a lengthy follow-up letter, also published by AJE, I discuss these seven studies and renew my call for the immediate early use of hydroxychloroquine in high-risk patients
These seven studies include: an additional 400 high-risk patients treated by Dr. Vladimir Zelenko, with zero deaths; four studies totaling almost 500 high-risk patients treated in nursing homes and clinics across the U.S., with no deaths; a controlled trial of more than 700 high-risk patients in Brazil, with significantly reduced risk of hospitalization and two deaths among 334 patients treated with hydroxychloroquine; and another study of 398 matched patients in France, also with significantly reduced hospitalization risk. Since my letter was published, even more doctors have reported to me their completely successful use.
Beyond these studies of individual patients, we have seen what happens in large populations when these drugs are used. These have been "natural experiments." In the northern Brazil state of Pará, COVID-19 deaths were increasing exponentially. On April 6, the public hospital network purchased 75,000 doses of azithromycin and 90,000 doses of hydroxychloroquine. Over the next few weeks, authorities began distributing these medications to infected individuals. Even though new cases continued to occur, on May 22 the death rate started to plummet and is now about one-eighth what it was at the peak.
First, as all know, the medication has become highly politicized. For many, it is viewed as a marker of political identity, on both sides of the political spectrum. Nobody needs me to remind them that this is not how medicine should proceed. We must judge this medication strictly on the science. When doctors graduate from medical school, they formally promise to make the health and life of the patient their first consideration, without biases of race, religion, nationality, social standing—or political affiliation. Lives must come first.
Second, the drug has not been used properly in many studies. Hydroxychloroquine has shown major success when used early in high-risk people but, as one would expect for an antiviral, much less success when used late in the disease course. Even so, it has demonstrated significant benefit in large hospital studies in Michigan and New York City when started within the first 24 to 48 hours after admission.
In fact, as inexpensive, oral and widely available medications, and a nutritional supplement, the combination of hydroxychloroquine, azithromycin or doxycycline, and zinc are well-suited for early treatment in the outpatient setting. The combination should be prescribed in high-risk patients immediately upon clinical suspicion of COVID-19 disease, without waiting for results of testing. Delays in waiting before starting the medications can reduce their efficacy.
Third, concerns have been raised by the FDA and others about risks of cardiac arrhythmia, especially when hydroxychloroquine is given in combination with azithromycin. The FDA based its comments on data in its FDA Adverse Event Reporting System. This reporting system captured up to a thousand cases of arrhythmias attributed to hydroxychloroquine use. In fact, the number is likely higher than that, since the reporting system, which requires physicians or patients to initiate contact with the FDA, appreciably undercounts drug side effects.
But what the FDA did not announce is that these adverse events were generated from tens of millions of patient uses of hydroxychloroquine for long periods of time, often for the chronic treatment of lupus or rheumatoid arthritis. Even if the true rates of arrhythmia are ten-fold higher than those reported, the harms would be minuscule compared to the mortality occurring right now in inadequately treated high-risk COVID-19 patients.
This fact is proven by an Oxford University study of more than 320,000 older patients taking both hydroxychloroquine and azithromycin, who had arrhythmia excess death rates of less than 9/100,000 users, as I discuss in my May 27 paper cited above. A new paper in the American Journal of Medicine by established cardiologists around the world fully agrees with this.
https://www.newsweek.com/key-defeati...pinion-1519535
ExpressLane (06-15-2021)
cancel2 2022 (06-15-2021)
Hydroxy does not work, it causes more deaths. https://blogs.sciencemag.org/pipelin...0/09/hard-data I know, it is a scientific study, so it does not count to rightys.
cancel2 2022 (06-15-2021)
Bookmarks